Iterum Therapeutics plc

Ownership Transactions Reported by 9 Insiders

Symbol
ITRM on Nasdaq
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland

There are no Buy or Sell transactions made by insiders since 1/30/2024

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ronald Hunt Director $483K Jan 13, 2025
Michael W. Dunne Director $308K Aug 6, 2024
Corey N. Fishman Chief Executive Officer, Director $192K Aug 6, 2024
Beth Hecht Director $26.4K Jun 15, 2023
Mark Chin Director $25.6K Jun 15, 2023
Sailaja Puttagunta Chief Medical Officer $14.5K Dec 1, 2023
Judith M. Matthews Chief Financial Officer Mar 31, 2023
David G. Kelly Director Jun 15, 2022
Brenton K. Ahrens Director Dec 23, 2022

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.